Skip to main content
. 2021 Jan 8;14(1):e238145. doi: 10.1136/bcr-2020-238145

Table 1.

Free T4, free T3 and TSH trend from the patient’s initial presentation with thyrotoxicosis, with recovery to a euthyroid state following treatment modification

Date TSH (mIU/L) Free T4 (pmol/L) Free T3 (pmol/L) Treatment
09/08/2019 <0.008 52 12.4 Initiation of carbimazole therapy
26/08/2019 <0.008 117 24.4 Addition of prednisolone to carbimazole therapy
30/08/2019 <0.008 96 18.6
09/09/2019 <0.008 49 8.7 Cessation of carbimazole therapy
10/10/2019 0.012 21 4.5
12/11/2019 3.008 13 3.5
27/12/2019 1.506 19 5.4 Cessation of prednisolone
17/02/2020 1.040 17 5.2

T3, tri-iodothyronine; T4, thyroxine; TSH, thyroid-stimulating hormone.